Aduro Biotech Inc. (ADRO) Soars 5.11% on March 14

Equities Staff  |

Aduro Biotech Inc. (ADRO) had a good day on the market for Wednesday March 14 as shares jumped 5.11% to close at $9.25. About 874,478 shares traded hands on 4,593 trades for the day, compared with an average daily volume of 561,905 shares out of a total float of 81.01 million. After opening the trading day at $8.80, shares of Aduro Biotech Inc. stayed within a range of $9.30 to $8.65.

With today's gains, Aduro Biotech Inc. now has a market cap of $749.31 million. Shares of Aduro Biotech Inc. have been trading within a range of $14.05 and $5.83 over the last year, and it had a 50-day SMA of $6.88 and a 200-day SMA of $9.51.

Aduro Biotech Inc is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies that transform the treatment of different diseases.

Aduro Biotech Inc. is based out of Berkeley, CA and has some 143 employees. Its CEO is .

For a complete fundamental analysis of Aduro Biotech Inc., check out Equities.com’s Stock Valuation Analysis report for ADRO.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

Aduro Biotech Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Aduro Biotech Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ADRO’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG